Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

2(28.6%)

Phase 1

2(28.6%)

Phase 4

1(14.3%)

Early Phase 1

1(14.3%)

N/A

1(14.3%)

7Total

Phase 2(2)

Phase 1(2)

Phase 4(1)

Early Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT07032116Not Yet Recruiting

YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1

Role: collaborator

NCT06393413Early Phase 1Completed

To Explore the Therapeutic Potential of Jiedu Yizhi Formula for Alzheimer 's Disease

Role: lead

NCT01715376Completed

Effects of Integrated Treatment by Traditional Chinese and Western Medicine in Reducing Cardiovascular Events

Role: lead

NCT02641886Not ApplicableCompleted

The Study of Jian Pi Yi Shen Hua Tan Granules in Cognitive Impairment After Acute Cerebral Infarction

Role: collaborator

NCT02539277Phase 4Unknown

A Post-marketing Research on Jinyebaidu Granule in Treating Patients With Acute Upper Respiratory Infection

Role: collaborator

NCT02452489Phase 1Unknown

Different Acupoints Compatibility Difference of the Effect of Treatment of the Diabetic Gastroparesis

Role: lead

NCT02448602Phase 1Unknown

Different Acupoints Compatibility Difference of the Effect of Treatment of the Primary Insomnia

Role: lead

NCT01274936Phase 2Unknown

Qishe Pill for Cervical Radiculopathy

Role: collaborator

NCT01939236Phase 2Completed

Traditional Chinese Medicine for Treatment of Chronic Heart Failure

Role: collaborator

All 9 trials loaded